- Hans-Georg
Rammensee (born 12
April 1953) is a
German immunologist and
cancer researcher. He has been
Chair Professor and Head of the
Department of Immunology...
-
Pascolo (CSO),
Florian von der
Mulbe (COO), Günther Jung, and Hans-Georg
Rammensee.
CureVac has
approximately 375
employees since May 2018. At the beginning...
- Jung,
Institute of
Organic Chemistry, in
cooperation with Hans-Georg
Rammensee,
Institute of
Immunology and Cell
Biology (both:
University of Tübingen)...
- for
cancer treatment and vaccines) was
conducted by
groups led by H. G.
Rammensee and G. Jung. This work
contributed to the Ph.D. and
later research of...
-
Retrieved 20
December 2020.
Probst J,
Weide B,
Scheel B,
Pichler BJ, ****r I,
Rammensee HG,
Pascolo S (August 2007). "Spontaneous
cellular uptake of exogenous...
- doi:10.1111/j.1399-0039.1993.tb01980.x. PMID 8475491.
Undlien D,
Friede T,
Rammensee H,
Joner G, Dahl-Jørgensen K, Søvik O,
Akselsen H,
Knutsen I, Rønningen...
- 12 (5): 1504–11. doi:10.1021/bm1014624. PMC 3305786. PMID 21438624.
Rammensee, S.; Slotta, U.; Scheibel, T. & Bausch, A. R. (2008). "****embly mechanism...
- 3171/2013.2.FOCUS1313. PMID 23634918. Haen SP,
Pereira PL,
Salih HR,
Rammensee HG,
Gouttefangeas C (2011). "More Than Just
Tumor Destruction: Immunomodulation...
- the project's
multiple vaccine candidates. In
March 2020, Hans-Georg
Rammensee,
professor of
immunology at
University of Tübingen and co-founder of CureVac...
-
Raible –
romanistics (Albert
Ludwigs University of Freiburg) Hans-Georg
Rammensee –
immunology (Max
Planck Institute for
Developmental Biology, Tübingen)...
